Person · CIK 1294192

Margaret A Horn

Chief Operating Officer at Revolution Medicines; director at Sangamo Therapeutics

Earlier: Kosan Biosciences and Genencor International

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$37.8M

Noticed on Form 144$29.9M

Bought on Form 4$0

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Revolution Medicines RVMD	Common Stock	Directly	149,680	Sep 16, 2026 · Filing · EDGAR
Revolution Medicines RVMD	Stock Option (Right to Buy) exercise $26.50, expires Feb 28, 2033, into Common Stock	Directly	114,275	Jun 17, 2026 · Filing · EDGAR
Revolution Medicines RVMD	Stock Option (Right to Buy) exercise $40.74, expires Feb 28, 2035, into Common Stock	Directly	75,075	Jun 17, 2026 · Filing · EDGAR
Revolution Medicines RVMD	Stock Option (Right to Buy) exercise $29.80, expires Feb 28, 2034, into Common Stock	Directly	71,750	Jun 17, 2026 · Filing · EDGAR
Sangamo Therapeutics SGMO	Common Stock	Directly	82,650	Jun 12, 2025 · Filing · EDGAR
Sangamo Therapeutics SGMO	Stock Option (Right to Buy) exercise $0.50, expires Jun 11, 2035, into Common Stock	Directly	50,000	Jun 12, 2025 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2026	$990K	$984K
Q2 2026	$15.9M	$15.8M
Q1 2026	$8M	$6.5M
Q4 2025	$372K	$367K
Q3 2025	$219K	$219K
Q2 2025	$698K	$135K
Q1 2025	$119K	$132K
Q4 2024	$2.7M	$2.7M
Q3 2024	$191K	$180K
Q2 2024	$165K	$172K
Q1 2024	$898K	$843K
Q4 2023	$1.2M	$1.1M
Q3 2023	$732K	$724K
Q2 2023	$52K	$54K
Q1 2023	$27K	Not machine-readable
Q4 2022	$1.1M	Not machine-readable
Q3 2022	$24K	Not machine-readable
Q2 2022	$20K	Not machine-readable
Q1 2022	$6K	Not machine-readable
Q4 2021	$12K	Not machine-readable
Q3 2021	$14K	Not machine-readable
Q2 2021	$16K	Not machine-readable
Q1 2021	$1.9M	Not machine-readable
Q4 2020	$2.5M	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Revolution Medicines RVMD · Etrade Financial · 10b5-1 plan adopted May 31, 2023 · 13 notices
Sep 15, 2026	4,830 · ~$984K	Sep 15, 2026	Partly sold Sold 76 at $195.01 on Sep 16 · $15K likely match Form 4	Filing · EDGAR
Jun 15, 2026	3,486 · ~$536K	Jun 15, 2026	Not sold within 90 days	Filing · EDGAR
Mar 13, 2026	4,722 · ~$470K	Mar 16, 2026	Partly sold Sold 4,583 at $99.48 on Mar 17 · $456K likely match Form 4	Filing · EDGAR
Dec 12, 2025	4,711 · ~$367K	Dec 15, 2025	Partly sold Sold 1,700 at $102.90 on Jan 7 · $175K likely match Form 4	Filing · EDGAR
Sep 15, 2025	4,712 · ~$219K	Sep 15, 2025	Not sold within 90 days	Filing · EDGAR
Jun 13, 2025	3,320 · ~$135K	Jun 16, 2025	Not sold within 90 days	Filing · EDGAR
Mar 14, 2025	3,406 · ~$132K	Mar 17, 2025	Partly sold Sold 3,058 at $39.04 on Mar 17 · $119K likely match Form 4	Filing · EDGAR
Dec 16, 2024	4,271 · ~$192K	Dec 16, 2024	Not sold within 90 days	Filing · EDGAR
Sep 16, 2024	4,271 · ~$180K	Sep 16, 2024	Not sold within 90 days	Filing · EDGAR
Jun 14, 2024	4,271 · ~$172K	Jun 17, 2024	Not sold within 90 days	Filing · EDGAR
Mar 15, 2024	2,404 · ~$79K	Mar 15, 2024	Not sold within 90 days	Filing · EDGAR
Dec 14, 2023	2,908 · ~$70K	Dec 18, 2023	Not sold within 90 days	Filing · EDGAR
Dec 14, 2023	2,908 · ~$70K	Dec 18, 2023	Not sold within 90 days	Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 12, 2026 · 2 notices
Jun 15, 2026	90,000 · ~$13.8M	Jun 15, 2026	Sold as noticed Sold 90,000 in 2 sales, Jun 15 to Jun 17 · $14.4M Form 4	Filing · EDGAR
Jun 11, 2026	10,000 · ~$1.4M	Jun 11, 2026	Sold as noticed Sold 10,000 in 7 sales, Jun 11 to Jun 11 · $1.5M Form 4	Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 7, 2025 · 1 notice
Jan 7, 2026	75,000 · ~$6M	Jan 7, 2026	Partly sold Sold 73,300 in 2 sales, Jan 7 to Jan 7 · $7.4M likely match Form 4	Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 22, 2024 · 1 notice
Oct 11, 2024	50,000 · ~$2.5M	Oct 11, 2024	Sold as noticed Sold 50,000 at $50.34 on Oct 11 · $2.5M Form 4	Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 29, 2023 · 7 notices
Mar 11, 2024	23,671 · ~$763K	Mar 11, 2024	Sold as noticed Sold 23,671 in 2 sales, Mar 11 to Mar 12 · $806K Form 4	Filing · EDGAR
Dec 15, 2023	5,000 · ~$131K	Dec 15, 2023	Sold as noticed Sold 5,000 at $26.64 on Dec 15 · $133K Form 4	Filing · EDGAR
Dec 6, 2023	5,000 · ~$118K	Dec 6, 2023	Sold as noticed Sold 5,000 at $25.00 on Dec 6 · $125K Form 4	Filing · EDGAR
Oct 16, 2023	25,000 · ~$748K	Oct 16, 2023	Sold as noticed Sold 24,900 in 4 sales, Oct 16 to Oct 16 · $846K Form 4	Filing · EDGAR
Sep 15, 2023	5,000 · ~$163K	Sep 15, 2023	Sold as noticed Sold 5,000 at $32.08 on Sep 15 · $160K Form 4	Filing · EDGAR
Aug 31, 2023	10,000 · ~$333K	Aug 31, 2023	Sold as noticed Sold 10,100 in 2 sales, Aug 31 to Oct 16 · $343K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Aug 15, 2023	5,000 · ~$150K	Aug 15, 2023	Sold as noticed Sold 5,000 in 2 sales, Aug 15 to Aug 15 · $153K Form 4	Filing · EDGAR
Revolution Medicines RVMD · Etrade Financial · 10b5-1 plan adopted Mar 29, 2023 · 1 notice
Sep 20, 2023	2,514 · ~$79K	Sep 18, 2023	Sold as noticed Sold 2,514 at $31.31 on Sep 18 · $79K Form 4	Filing · EDGAR
Revolution Medicines RVMD · Etrade Financial · No 10b5-1 plan stated · 1 notice
Jun 20, 2023	2,102 · ~$54K	Jun 20, 2023	Sold as noticed Sold 2,102 at $24.89 on Jun 20 · $52K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 24 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,891 at $199.30 on Sep 16, 2026 · $975K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,847 at $76.82 on Dec 16, 2025 · $372K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,775 at $45.82 on Sep 16, 2025 · $219K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 3,575 at $156.12 on Jun 16, 2025 · $558K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 3,510 at $39.83 on Jun 16, 2025 · $140K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,329 at $45.40 on Dec 16, 2024 · $197K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,331 at $44.19 on Sep 16, 2024 · $191K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 4,415 at $37.39 on Jun 17, 2024 · $165K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 2,914 at $31.58 on Mar 18, 2024 · $92K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Revolution Medicines (RVMD): Sold 2,993 at $25.90 on Dec 18, 2023 · $78K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 1,230 at $21.78 on Mar 17, 2023 · $27K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 1,220 at $22.94 on Dec 19, 2022 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 17,767 at $20.15 on Nov 7, 2022 · $358K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 17,767 at $20.41 on Oct 31, 2022 · $363K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 17,768 at $20.15 on Oct 26, 2022 · $358K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 1,267 at $19.04 on Sep 19, 2022 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 1,145 at $17.75 on Jun 17, 2022 · $20K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 321 at $18.61 on Mar 17, 2022 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 491 at $24.41 on Dec 17, 2021 · $12K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 479 at $30.02 on Sep 17, 2021 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 464 at $34.13 on Jun 17, 2021 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 35,000 at $55.00 on Feb 5, 2021 · $1.9M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 12,495 at $35.40 on Oct 2, 2020 · $442K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Revolution Medicines (RVMD): Sold 57,505 at $35.01 on Oct 1, 2020 · $2M (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Revolution Medicines RVMD Chief Operating Officer · filings 2020 to 2026 · sold $37.8M · $29.9M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 16, 2026	Sale under a 10b5-1 plan	−76	$195.01	$15K	154,571 direct	Filing · EDGAR
Sep 16, 2026	Sale under a 10b5-1 plan	−4,891	$199.30	$975K	149,680 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+573	$40.74	$23K	155,220 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+3,302	$29.80	$98K	158,522 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+25,725	$26.50	$682K	184,247 direct	Filing · EDGAR
Jun 17, 2026	Sale under a 10b5-1 plan	−29,600	$160.12	$4.7M	154,647 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−573			75,075 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−3,302			71,750 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−25,725			114,275 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted	+15,546	$40.74	$633K	173,768 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted	+44,854	$29.80	$1.3M	218,622 direct	Filing · EDGAR
Jun 15, 2026	Sale under a 10b5-1 plan	−60,400	$160.17	$9.7M	158,222 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−15,546			75,648 direct	Filing · EDGAR
Jun 15, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−44,854			75,052 direct	Filing · EDGAR
Jun 11, 2026	Option or RSU exercised or converted	+1,094	$42.45	$46K	159,316 direct	Filing · EDGAR
Jun 11, 2026	Option or RSU exercised or converted	+8,906	$40.74	$363K	168,222 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−1,315	$144.28	$190K	166,907 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−885	$145.15	$128K	166,022 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−700	$146.04	$102K	165,322 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−500	$147.27	$74K	164,822 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−1,800	$148.72	$268K	163,022 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−4,600	$149.64	$688K	158,422 direct	Filing · EDGAR
Jun 11, 2026	Sale under a 10b5-1 plan	−200	$150.17	$30K	158,222 direct	Filing · EDGAR
Jun 11, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−1,094			0 direct	Filing · EDGAR
Jun 11, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−8,906			91,194 direct	Filing · EDGAR
Mar 17, 2026	Sale under a 10b5-1 plan	−4,583	$99.48	$456K	157,570 direct	Filing · EDGAR
Mar 1, 2026	Grant or award from the company	+21,100			162,153 direct	Filing · EDGAR
Mar 1, 2026	Grant or award from the company Stock Option (Right to Buy)	+47,600			47,600 direct	Filing · EDGAR
Jan 7, 2026	Option or RSU exercised or converted	+51,406	$42.45	$2.2M	192,459 direct	Filing · EDGAR
Jan 7, 2026	Option or RSU exercised or converted	+23,594	$29.80	$703K	216,053 direct	Filing · EDGAR
Jan 7, 2026	Sale under a 10b5-1 plan	−53,096	$100.02	$5.3M	162,957 direct	Filing · EDGAR
Jan 7, 2026	Sale under a 10b5-1 plan	−20,204	$101.79	$2.1M	142,753 direct	Filing · EDGAR
Jan 7, 2026	Sale under a 10b5-1 plan	−1,700	$102.90	$175K	141,053 direct	Filing · EDGAR
Jan 7, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−51,406			1,094 direct	Filing · EDGAR
Jan 7, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−23,594			119,906 direct	Filing · EDGAR
Dec 16, 2025	Sale under a 10b5-1 plan	−4,847	$76.82	$372K	141,053 direct	Filing · EDGAR
Sep 16, 2025	Sale under a 10b5-1 plan	−4,775	$45.82	$219K	145,900 direct	Filing · EDGAR
Jun 16, 2025	Sale under a 10b5-1 plan	−3,575	$156.12	$558K	154,647 direct	Filing · EDGAR
Jun 16, 2025	Sale under a 10b5-1 plan	−3,510	$39.83	$140K	150,675 direct	Filing · EDGAR
Mar 17, 2025	Sale under a 10b5-1 plan	−3,058	$39.04	$119K	153,533 direct	Filing · EDGAR
Mar 1, 2025	Grant or award from the company	+28,600			156,591 direct	Filing · EDGAR
Mar 1, 2025	Grant or award from the company Stock Option (Right to Buy)	+100,100			100,100 direct	Filing · EDGAR
Dec 16, 2024	Sale under a 10b5-1 plan	−4,329	$45.40	$197K	127,991 direct	Filing · EDGAR
Oct 11, 2024	Option or RSU exercised or converted	+44,631	$4.09	$183K	176,951 direct	Filing · EDGAR
Oct 11, 2024	Option or RSU exercised or converted	+5,369	$4.09	$22K	182,320 direct	Filing · EDGAR
Oct 11, 2024	Sale under a 10b5-1 plan	−50,000	$50.34	$2.5M	132,320 direct	Filing · EDGAR
Oct 11, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−44,631			0 direct	Filing · EDGAR
Oct 11, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−5,369			97,382 direct	Filing · EDGAR
Sep 16, 2024	Sale under a 10b5-1 plan	−4,331	$44.19	$191K	132,320 direct	Filing · EDGAR
Jun 17, 2024	Sale under a 10b5-1 plan	−4,415	$37.39	$165K	136,651 direct	Filing · EDGAR
Mar 18, 2024	Sale under a 10b5-1 plan	−2,914	$31.58	$92K	139,553 direct	Filing · EDGAR
Mar 12, 2024	Option or RSU exercised or converted	+7,936	$4.09	$32K	150,403 direct	Filing · EDGAR
Mar 12, 2024	Sale under a 10b5-1 plan	−7,936	$34.07	$270K	142,467 direct	Filing · EDGAR
Mar 12, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−7,936			44,631 direct	Filing · EDGAR
Mar 11, 2024	Option or RSU exercised or converted	+15,735	$4.09	$64K	158,202 direct	Filing · EDGAR
Mar 11, 2024	Sale under a 10b5-1 plan	−15,735	$34.02	$535K	142,467 direct	Filing · EDGAR
Mar 11, 2024	Option or RSU exercised or converted Stock Option (Right to Buy)	−15,735			52,567 direct	Filing · EDGAR
Mar 1, 2024	Grant or award from the company	+41,000			142,467 direct	Filing · EDGAR
Mar 1, 2024	Grant or award from the company Stock Option (Right to Buy)	+143,500			143,500 direct	Filing · EDGAR
Dec 18, 2023	Sale under a 10b5-1 plan	−2,993	$25.90	$78K	101,467 direct	Filing · EDGAR

50 earlier transactions are in the filing list below.

Sangamo Therapeutics SGMO Director · filings 2022 to 2025

Date	Transaction	Shares	Held after	Source
Jun 12, 2025	Grant or award from the company	+25,000	82,650 direct	Filing · EDGAR
Jun 12, 2025	Grant or award from the company Stock Option (Right to Buy)	+50,000	50,000 direct	Filing · EDGAR
Jun 4, 2024	Grant or award from the company	+25,000	57,650 direct	Filing · EDGAR
Jun 4, 2024	Grant or award from the company Stock Option (Right to Buy)	+50,000	50,000 direct	Filing · EDGAR
Jun 1, 2023	Grant or award from the company	+13,900	32,650 direct	Filing · EDGAR
Jun 1, 2023	Grant or award from the company Stock Option (Right to Buy)	+27,750	27,750 direct	Filing · EDGAR
Dec 15, 2022	Grant or award from the company	+18,750	18,750 direct	Filing · EDGAR
Dec 15, 2022	Grant or award from the company Stock Option (Right to Buy)	+37,500	37,500 direct	Filing · EDGAR

Kosan Biosciences SVP, General Counsel · filings 2005 to 2007

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 2, 2007	Grant or award from the company Employee Stock Option (right to buy)	+45,000			45,000 direct	Filing · EDGAR
Jan 3, 2006	Grant or award from the company Employee Stock Options	+20,000	$4.46	$89K	20,000 direct	Filing · EDGAR
Dec 2, 2005	Grant or award from the company Employee Stock Options	+150,000	$7.21	$1.1M	150,000 direct	Filing · EDGAR

Genencor International Sr. VP, General Counsel, Sect. · filings 2004 to 2005

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 21, 2005	Tendered in a change of control Stock Option (Right to Buy)	−125,000			0 direct	Filing · EDGAR
Apr 21, 2005	Tendered in a change of control Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Apr 21, 2005	Tendered in a change of control Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Apr 21, 2005	Tendered in a change of control Stock Option (Right to Buy)	−45,000			0 direct	Filing · EDGAR
Apr 21, 2005	Tendered in a change of control Stock Option (Right to Buy)	−60,000			0 direct	Filing · EDGAR
Apr 20, 2005	Tendered in a change of control	−1,183	$19.25	$23K	0 direct	Filing · EDGAR
Apr 20, 2005	Tendered in a change of control	−1,100	$19.25	$21K	0 By Husband	Filing · EDGAR
Dec 9, 2004	Grant or award from the company Stock Option (Right to Buy)	+60,000			60,000 direct	Filing · EDGAR
Jun 15, 2004	Grant or award from the company Stock Option (Right to Buy)	+45,000			45,000 direct	Filing · EDGAR

All 83 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 18, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 15, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 17, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 15, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 15, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 15, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 11, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 19, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 13, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 3, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jan 9, 2026	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jan 7, 2026	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Dec 18, 2025	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 12, 2025	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Sep 18, 2025	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 15, 2025	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 18, 2025	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 16, 2025	Form 4	Sangamo Therapeutics SGMO	Filing · EDGAR
Jun 13, 2025	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 19, 2025	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 14, 2025	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 4, 2025	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 18, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 16, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Oct 15, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Oct 11, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Sep 18, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 16, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 20, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 14, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 6, 2024	Form 4	Sangamo Therapeutics SGMO	Filing · EDGAR
Mar 20, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 15, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 13, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 11, 2024	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Mar 5, 2024	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 19, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 15, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Dec 14, 2023	Form 144/A	Revolution Medicines RVMD	Filing · EDGAR
Dec 14, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Dec 8, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 6, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Oct 25, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Oct 18, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Oct 16, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Sep 20, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Sep 19, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 15, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Sep 1, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Aug 31, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Aug 17, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Aug 15, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 22, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 20, 2023	Form 144	Revolution Medicines RVMD	Filing · EDGAR
Jun 5, 2023	Form 4	Sangamo Therapeutics SGMO	Filing · EDGAR
Mar 21, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 3, 2023	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 21, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 19, 2022	Form 4	Sangamo Therapeutics SGMO	Filing · EDGAR
Dec 19, 2022	Form 3	Sangamo Therapeutics SGMO	Filing · EDGAR
Nov 9, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Nov 2, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Oct 28, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 21, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 22, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 21, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 3, 2022	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Dec 21, 2021	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Sep 21, 2021	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Jun 22, 2021	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Mar 8, 2021	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Feb 8, 2021	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Oct 2, 2020	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Feb 14, 2020	Form 4	Revolution Medicines RVMD	Filing · EDGAR
Feb 12, 2020	Form 3	Revolution Medicines RVMD	Filing · EDGAR
Jan 4, 2007	Form 4	Kosan Biosciences	Filing · EDGAR
Jan 5, 2006	Form 4	Kosan Biosciences	Filing · EDGAR
Dec 6, 2005	Form 4	Kosan Biosciences	Filing · EDGAR
Dec 6, 2005	Form 3	Kosan Biosciences	Filing · EDGAR
Apr 22, 2005	Form 4	Genencor International	Filing · EDGAR
Dec 13, 2004	Form 4	Genencor International	Filing · EDGAR
Jun 17, 2004	Form 4	Genencor International	Filing · EDGAR
Jun 17, 2004	Form 3	Genencor International	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.